Therapeutic targets and emerging treatment options in gastrointestinal acute graft-versus-host disease.

导出 LinkOut

翻译打印收藏纠错

作者： Anne S,Renteria ^[1] ; John E,Levine ^[1] ; James L M,Ferrara ^[2]

作者单位： Blood and Marrow Transplantation Program, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. ^[1] Hematologic Malignancies Translational Research Center, Blood and Marrow Transplantation Program, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. ^[2]

关键词 Biomarkers GVHD Paneth cells graft-versus-host disease microbiome steroid-refractory GVHD treatment

DOI 10.1517/21678707.2016.1166949

PMID 30057862

发布时间 2022-03-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览7

Expert opinion on orphan drugs

2016年4卷5期

469-484页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Therapeutic targets and emerging treatment options in gastrointestinal acute graft-versus-host disease.

Expert opinion on orphan drugs

相似文献

Expert opinion on orphan drugs

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Therapeutic targets and emerging treatment options in gastrointestinal acute graft-versus-host disease.

Expert opinion on orphan drugs

相似文献

Expert opinion on orphan drugs

相关期刊

检索历史清除